

Pulmonx Corp
•0001127537
Pulmonx is a medical technology company focused on developing and commercializing minimally invasive treatments for lung diseases. Their key product, the Zephyr® Valve, is a clinically proven bronchoscopic treatment for patients with severe COPD/emphysema. Pulmonx has achieved recognition for improving patients' quality of life.
90
Sehr VertrauenswürdigOffizielles Register
Zuletzt überprüft: 1/2/2026
KI-Qualitätsanalyse
Vertrauensscore-Details
Register verifiziert35/35
Qualitätsbewertung55/60
Nachrichtenstimmung0/5
Schnellzugriff
Website-Highlights
Pulmonx | Stories About Patients Treated with Zephyr Valves
Read Zephyr Valve patient stories and see how their lives have changed after having this minimally invasive procedure for COPD/Emphysema.
Investor Relations | Pulmonx Corporation
The Investor Relations website contains information about Pulmonx Corporation's business for stockholders, potential investors, and financial analysts.
Pulmonx - PulmonxHomepage - German: LIBERATE - FEV1 - Percent Change - Gray Background | amChartsHomepage - German: LIBERATE - 6MWD - Change from Baseline - Gray | amChartsHomepage - German: LIBERATE - SGRQ - Change from Baseline - Gray | amCharts
chart created using amCharts live editor
Zuletzt aktualisiert: 1/2/2026